Free Market Groups, Advocates Oppose Codification of Most-Favored-Nation Drug Pricing
February 12th, 2026 The Honorable Members United States Congress Washington, D.C. 20515 RE: Coalition Opposing the Codification of Most-Favored-Nation Prescription Drug Pricing Dear Members of…
Read the full articleYou might also wanna read
Most-Favored Nation Drug Pricing: What U.S. Pricing Initiatives Mean for International Commercial Contracts
The Trump administration’s most-favored nation agreements with major pharmaceutical companies and recent initiatives by the Centers for Medi

U.S. launches tariff probe into Germany's pharmaceutical pricing policies
U.S. Trade Representative Jamieson Greer said Germany's proposal to reduce spending on medicines was "a serious step backwards."
Five EU countries seek unified response to US and pharma pressure on drug pricing
The U.S. and pharma companies are increasing the pressure on EU countries to pay more for medicines.

FTC Proposes Order to Resolve Anticompetitive Practices and Protect Healthcare Consumers
Author: Amy Asubonteng June 26, 2026 HRRC supports both the press release and the call to action given by the Federal Trade Commission. As h
Trump’s drug price crusade puts Europe on guard
UK has given in to pharma industry lobbying but some EU member states promise to stand firm
TrumpRx: Prescription Drug Price Comparison Platform with MFN Pricing Discounts
TrumpRx is a website that lists discounted drug prices from manufacturers that have agreed to Most Favored Nation (MFN) pricing. Americans c

Comments
Sign in to join the conversation.
No comments yet. Be the first.